Peptides for hair growth: separating signal from TikTok noise

What's this video probably claiming?

Based on the hashtag combination of #peptide, #growth, and #hair, this creator is almost certainly pitching one or more peptides as a hair loss solution. The likely suspects: GHK-Cu (copper peptide), which has genuine but limited research behind it, or possibly PTD-DBM, AHK-Cu, or the ever-popular BPC-157 being repurposed for follicle claims. Given the @fix.your.sh1t brand voice, this is probably framed as a "what your dermatologist isn't telling you" style take, positioning peptides as an underutilized fix for androgenetic alopecia or general thinning. The audience is being sold on the idea that these compounds meaningfully regrow hair, likely with before/afters, anecdotes, or cherry-picked lab data. Whether the creator distinguishes between topical and systemic use, or between rodent data and human trials, is the real question.

What does the science actually show?

GHK-Cu is the only peptide here with any meaningful human-relevant hair data. A 2007 study by Pyo et al. in the Journal of Cosmetic Dermatology found that topical GHK-Cu increased hair follicle size and stimulated proliferation of dermal papilla cells in vitro. That's cell culture data, not a randomized controlled trial. A small 2018 study by Gupta and Venkataraman in the International Journal of Trichology noted copper peptides showed promise in cosmetic formulations for hair density, but sample sizes were under 40 subjects and follow-up was short. BPC-157 has zero published human trials for hair. TB-500 and thymosin-related peptides have anecdotal wound-healing overlap, but nobody has run a serious hair-specific trial. MK-677's theoretical mechanism through IGF-1 stimulation is real, but translating elevated IGF-1 into reliable, measurable hair regrowth in humans has not been demonstrated in controlled research.

Where does the social media noise diverge from clinical reality?

The gap here is enormous. TikTok peptide content routinely skips the delivery problem entirely. GHK-Cu applied topically has poor skin penetration without a proper carrier system. Most over-the-counter formulations don't solve this, yet creators talk about copper peptides as if rubbing a serum on your scalp is equivalent to the concentrations used in lab studies. Systemic peptides like BPC-157 are being discussed as hair treatments because of vague claims about "stem cell activation" and "growth factor upregulation," language that sounds scientific but maps to nothing in peer-reviewed trichology literature. There's also consistent conflation of anagen phase extension (which finasteride demonstrably does, per the landmark Kaufman et al. 1998 NEJM study showing 83% of men maintained or increased hair count) with the far more speculative mechanisms peptide advocates describe. The FDA has not approved any injectable peptide for hair loss indications.

What should you actually know?

If you're losing hair and considering peptides, here's the honest picture. The only treatments with strong human evidence are minoxidil (FDA-approved, well-studied at 2% and 5% concentrations) and finasteride (proven in multiple large RCTs). Topical GHK-Cu as an adjunct is plausible but not proven at clinical scale. Injectable peptides for hair are experimental in the most literal sense: no phase 2 or 3 trials, no established dosing protocols, and real unknowns around long-term systemic effects. The creator's enthusiasm may be genuine, but enthusiasm isn't a study design. If a telehealth provider is recommending injectable peptides specifically for hair loss without disclosing the absence of human trial data, that's a red flag worth asking about directly. Anyone using compounded peptides should understand these are not FDA-approved formulations and have not been evaluated for efficacy in this application.